Germline mutations in the TP53 gene are associated with Li–Fraumeni syndrome (LFS) and are responsible for the majority of ACT cases in young children worldwide, which merits genotyping and counseling, including for low-penetrance TP53 mutation carriers [6,7]. This evidence concerns the gene TP53 and Li-Fraumeni syndrome.